13D/13G Filings - Equillium Inc. (EQ)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-11-14
9:50 pm
Purchase		2024-09-3013GEquillium, Inc.
EQ		Decheng Capital Management IV (Cayman) LLC5,733,021
15.600%		5,733,021increase
(New Position)		Filing
History
2024-01-19
06:03 am
Purchase		2023-12-3113GEquillium, Inc.
EQ		TAKEDA PHARMACEUTICAL CO LTD1,842,977
5.200%		1,842,977increase
(New Position)		Filing
History
2023-03-03
09:27 am
Sale		2023-02-2813GEquillium, Inc.
EQ		VICTORY CAPITAL MANAGEMENT INC1,352,210
3.930%		-2,840,444decrease
(-67.75%)		Filing
History
2023-01-31
09:41 am
Purchase		2022-12-3113GEquillium, Inc.
EQ		VICTORY CAPITAL MANAGEMENT INC4,192,654
12.200%		66,987increase
(+1.62%)		Filing
History
2022-02-14
11:57 am
Purchase		2021-12-3113GEquillium, Inc.
EQ		Decheng Capital Management III (Cayman) LLC4,447,308
15.130%		4,447,308increase
(New Position)		Filing
History
2022-02-01
12:39 pm
Purchase		2021-12-3113GEquillium, Inc.
EQ		VICTORY CAPITAL MANAGEMENT INC4,125,667
14.040%		1,327,535increase
(+47.44%)		Filing
History
2021-02-16
5:21 pm
Purchase		2021-02-0513DEquillium, Inc.
EQ		Decheng Capital Global Life Sciences Fund IV, L.P.5,733,021
19.700%		5,733,021increase
(New Position)		Filing
History
2021-02-03
09:34 am
Purchase		2020-12-3113GEquillium, Inc.
EQ		VICTORY CAPITAL MANAGEMENT INC2,798,132
11.320%		564,408increase
(+25.27%)		Filing
History